OmniPod - PODD Short-Term Debt to Capital

PODD (Insulet Corporation) - company brandmark

Insulet Corporation is transforming diabetes treatment by introducing innovative tubeless pumps and expanding its global presence. The company's environmental development vector is based on recycling consumables and minimizing factory emissions. Robotic assembly in sterile zones guarantees high product quality. The short-term debt-to-equity ratio demonstrates financial stability, where 0.00 indicates the current level of this metric.

PODD - Insulet Corp Short-Term Debt to Equity Ratio over the range 07/04/2022 - 10/30/2026
Brand item of Insulet

Insulet Corporation is developing high-tech ecosystems through strategic integration with glucose monitoring manufacturers. The metric compares the volume of short-term liabilities against the net asset value, determining the degree of capital dependence on short-term loans. A stable current short-term debt-to-equity ratio confirms the predictability of payments in the absence of aggressive debt expansion. Such a conservative balance sheet structure indicates the business's financial stability during a period of technological scaling.

Main competitors

Short-Term Debt to Equity Boston Scientific Inc (BSX)|EW: Current Liabilities to Equity|Short-Term Debt to Capital RMD (ResMed Inc.)|Zimmer (ZBH) - Current Liabilities to Capital|CooperCompanies - Short-Term Debt to Capital|Invisalign (ALGN) - Short-Term Debt to Equity Ratio|GMED: Short-Term Debt to Capital|TMDX - Short-Term Debt to Capital Coefficient|ATEC (Alphatec Holdings, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital artivion.com|Short-Term Debt to Equity Enovis (ENOV)|Short-Term Debt to Equity IART (Integra LifeSciences Corp)|Short-Term Debt to Capital ESTA (Motiva)|Short-Term Debt to Capital Coefficient iLet Bionic Pancreas (BBNX)|IRMD: Short-Term Debt to Equity Ratio|Current Liabilities to Equity EMBC|TNDM: Short-Term Debt to Capital|Current Liabilities to Capital AxoGen Inc (AXGN)|SIBN (SI-BONE Corp) - Short-Term Debt to Capital|Short-Term Debt to Capital Ratio OFIX (Orthofix Corp)|Short-Term Debt to Equity Ratio BVS (Bioventus Inc.)|KIDS (orthopediatrics.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Treace Medical Concepts, Inc. TMCI|SRTA - Short-Term Debt to Equity Ratio|Carlsmed Corp - Short-Term Debt to Capital|Current Liabilities to Capital RxSight Ophthalmic|CLPT: Short-Term Debt to Capital|Short-Term Debt to Capital Ratio STXS|STIM (Neuronetics) - Short-Term Debt to Capital|Sight Sciences Inc. (SGHT) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital OBIO|Short-Term Debt to Equity Ratio anikatherapeutics.com ANIK|Short-Term Debt to Capital NSPR (InspireMD, Inc.)|Short-Term Debt to Capital Jin Medical International Ltd. ZJYL|VANI - Short-Term Debt to Equity|XTNT: Short-Term Debt to Equity|NMTC (NeuroOne Corp) - Short-Term Debt to Equity Ratio|Modular Medical, Inc. - Ratio of Short-Term Indebtedness to Capital|MYO (Myomo, Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital envoymedical.com COCH|Short-Term Debt to Equity Vivos Therapeutics, Inc. (VVOS)|enVVeno Medical Corporation (NVNO) - Short-Term Indebtedness to Equity|Sintx Technologies, Inc. - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Tenon Medical Inc TNON|ReWalk Robotics Ltd. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Autonomix Medical, Inc. AMIX|INVO Fertility (IVF) - Short-Term Debt to Equity|Current Liabilities to Equity BBLG (Bone Biologics Corp.)|Short-Term Debt to Equity Axonics Modulation Technologies|Short-Term Debt to Equity Ratio Biolase Inc. (BIOL)|Short-Term Debt to Capital DYNT|FNA - Current Liabilities to Capital|Short-Term Debt to Equity INVO Bioscience INVO